NIH-funded research NIH-funded research

Understanding protein forms in disease with advanced mass spectrometry

Official title: A multi-level mass spectrometry pipeline for the analysis of whole proteoforms and their complexes

Funded at University of Oklahoma · NIH-11361645 · Data updated 2026-11-12

A researchers team will use a cutting-edge mass spectrometry approach to map and measure the full shape and connections of disease-related proteins in human biology.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Oklahoma
NIH-funded
Lab location1 site (Norman, United States)
Project startSeptember 1, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$380,398
NIH project number5R35GM147397-05
Project IDNIH-11361645 on NIH RePORTER

Who could benefit from this research

Could help

Patients with diseases where proteoform alterations play a role may benefit from future biomarker discovery and tailored treatments.

Less likely to help

No direct patient benefit is guaranteed; outcomes are primarily scientific and methodological in nature.

What this research studies

This project aims to analyze proteoforms—the different ways proteins can exist in the body—at multiple levels to understand how they contribute to disease. By improving the ability to determine exact protein structure, how abundant each form is, and how protein complexes behave, the study seeks to reveal new molecular insights that could inform future therapies. The work focuses on developing and applying a top-down proteomics pipeline that can handle large protein forms and their interactions in intact biological samples. Results could help identify new biomarkers and mechanisms underlying disease progression. The research is led by Luca Fornelli at the University of Oklahoma, with a focus on advancing proteomics technologies to better study human disease biology.

Why it matters

Potential benefit: If successful, the project could provide deeper molecular insights into disease processes and generate data that may guide development of targeted diagnostics or therapies.

How similar studies have gone: Top-down proteomics has shown promise, but translating it to large proteoforms and complex assemblies remains a challenge; this project aims to push those boundaries.

Where this research is happening

  • University of Oklahoma
    Norman, United States
    Active

Researchers

  • Principal investigator: Fornelli, Luca — University of Oklahoma
  • Study coordinator: Fornelli, Luca

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.